| All, n= 90 (%) | AS-Present, n=19 (%) | AS-Absent, n=71 (%) | p-value | |
|---|---|---|---|---|
| Aortic Valve Disease | ||||
| Normal Leaflets | 35 (38.9) | 2 (10.5) | 33 (46.5) | n/a |
| Aortic Sclerosis | 42 (46.7) | 4 (21.1) | 38 (53.5) | |
| Aortic Stenosis | 13 (14.4) | 13 (68.4) | 0 (0) | |
| Mitral Valve Disease | ||||
| Normal Leaflets | 45 (50.0) | 6 (31.6) | 39 (54.9) | 0.10b |
| Thickened Leaflets | 41 (45.6) | 11 (57.9) | 30 (42.3) | |
| Mitral Stenosis | 4 (4.4) | 2 (10.5) | 2 (2.8) | |
| Right Ventricular Size | ||||
| Normal Size | 21 (23.3) | 4 (21.1) | 17 (23.9) | 0.30b |
| Mildly Enlarged | 23 (25.6) | 5 (26.3) | 18 (25.4) | |
| Moderately Enlarged | 20 (22.2) | 7 (36.8) | 13 (18.3) | |
| Severely Enlarged | 26 (28.9) | 3 (15.8) | 23 (32.4) | |
| Right Ventricular Function | ||||
| Normal Function | 31 (34.4) | 6 (31.6) | 25 (35.2) | 0.31b |
| Mildly Reduced | 16 (17.8) | 4 (21.1) | 12 (16.9) | |
| Moderately Reduced | 22 (24.4) | 7 (36.8) | 15 (21.1) | |
| Severely Reduced | 21 (23.3) | 2 (10.5) | 19 (26.8) | |
| Mitral Regurgitation | 24 (26.7) | 8 (42.1) | 16 (22.5) | 0.14a |
| Pericardial Effusion | 22 (24.4) | 6 (31.6) | 16 (22.5) | 0.55a |
| RVSP, n=88 | 68.3 ± 2.1 | 72.3 ± 3.4 | 67.2 ± 2.5 | 0.24a |
*Statistically significant at p<0.05, aunpaired t-test with Welch’s correction bFischer-exact test. Variance= standard error
The core management principles of patients with PAH on advanced pulmonary vasodilator therapy receiving TAVR at our center
Transthoracic echocardiogram data at pulmonary arterial hypertension diagnosis